<bill session="118" type="s" number="3039" updated="2025-11-18T21:32:17Z">
  <state datetime="2023-10-04">REFERRED</state>
  <status>
    <introduced datetime="2023-10-04"/>
  </status>
  <introduced datetime="2023-10-04"/>
  <titles>
    <title type="display">Federal Kratom Consumer Protection Act</title>
    <title type="short" as="introduced">Federal Kratom Consumer Protection Act</title>
    <title type="official" as="introduced">A bill to protect access to kratom.</title>
  </titles>
  <sponsor bioguide_id="L000577"/>
  <cosponsors>
    <cosponsor bioguide_id="B001288" joined="2023-10-18"/>
  </cosponsors>
  <actions>
    <action datetime="2023-10-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-10-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills>
    <bill session="118" type="h" number="5905" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Advisory bodies"/>
    <term name="Congressional oversight"/>
    <term name="Consumer affairs"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Food supply, safety, and labeling"/>
    <term name="Government information and archives"/>
    <term name="Research administration and funding"/>
  </subjects>
  <amendments/>
  <summary date="2023-10-26T19:51:12Z" status="Introduced in Senate">Federal Kratom Consumer Protection Act

This bill requires the Food and Drug Administration (FDA) to hold a hearing and establish a task force on the health and safety of products with kratom (an herbal substance that produces opioid- and stimulant-like effects). It also prohibits the FDA from regulating kratom products in a manner that is more restrictive as compared to regulations for food, dietary supplements, or dietary ingredients.</summary>
</bill>
